Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Capital Leases (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Capital Leases for 2 consecutive years, with $43000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Capital Leases fell 63.25% to $43000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $43000.0, a 63.25% decrease, with the full-year FY2024 number at $100000.0, changed N/A from a year prior.
  • Capital Leases was $43000.0 for Q3 2025 at Pyxis Oncology, down from $62000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $135000.0 in Q2 2024 to a low of $43000.0 in Q3 2025.